{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:00:27Z","timestamp":1781053227043,"version":"3.54.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.virol.2026.110977","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:51:23Z","timestamp":1780069883000},"page":"110977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Three-dimensional culture models of hepatitis B virus infection: Progress, challenges, and opportunities"],"prefix":"10.1016","volume":"622","author":[{"given":"Tasneem","family":"Farhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keila Dias","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Arbuthnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubendran","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2249-7615","authenticated-orcid":false,"given":"Mohube Betty","family":"Maepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.virol.2026.110977_bib1","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.stemcr.2016.10.003","article-title":"Detecting genetic mosaicism in cultures of human pluripotent stem cells","volume":"7","author":"Baker","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.virol.2026.110977_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.721975","article-title":"HBV-specific CD8+ T-Cell tolerance in the liver","volume":"12","author":"Baudi","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib4","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","author":"Bertoletti","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-genom-083115-022536","article-title":"Lessons from HeLa cells: the ethics and policy of biospecimens","volume":"17","author":"Beskow","year":"2016","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2014.04.026","article-title":"The role of kupffer cells in hepatitis B and hepatitis C virus infections","volume":"61","author":"Boltjes","year":"2014","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.virol.2026.110977_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate cells, hepatocytes, and endothelial cells imprint the kupffer cell identity on monocytes colonizing the liver macrophage niche","volume":"51","author":"Bonnardel","year":"2019","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.virol.2026.110977_bib8","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2026.110977_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582292","article-title":"The multiple functions of B cells in chronic HBV infection","volume":"11","author":"Cai","year":"2020","journal-title":"Front. Immunol."},{"issue":"29","key":"10.1016\/j.virol.2026.110977_bib10","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.3748\/wjg.v27.i29.4784","article-title":"Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells","volume":"27","author":"Cao","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29546","article-title":"The downregulation of tapasin in dendritic cell regulates CD8+ T cell autophagy to hamper hepatitis B viral clearance in the induced pluripotent stem cell-derived hepatocyte organoid","volume":"96","author":"Chen","year":"2024","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.virol.2026.110977_bib12","first-page":"291","article-title":"3D Co-Culture of hepatocyte, a hepatic stellate cell line, and stem cells for developing a bioartificial liver prototype","volume":"11","author":"Christine Verawaty Sibuea","year":"2020","journal-title":"International Journal of Technology"},{"issue":"7","key":"10.1016\/j.virol.2026.110977_bib13","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/biomedicines12071624","article-title":"Preclinical models of hepatocellular carcinoma: current utility, limitations, and challenges","volume":"12","author":"Cigliano","year":"2024","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.virol.2026.110977_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-03924-0","article-title":"Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal hepatitis B viral genome in preclinical models","volume":"12","author":"Clark","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bpg.2017.04.014","article-title":"Animal models of HBV infection","volume":"31","author":"Dandri","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"106","key":"10.1016\/j.virol.2026.110977_bib16","first-page":"349","article-title":"Stem cell-derived liver cells for drug testing and disease modeling","volume":"19","author":"Davidson","year":"2015","journal-title":"Discov. Med."},{"key":"10.1016\/j.virol.2026.110977_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60747","article-title":"Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma","volume":"10","author":"De Crignis","year":"2021","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.virol.2026.110977_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/cells8050403","article-title":"Current challenges of iPSC-Based disease modeling and therapeutic implications","volume":"8","author":"Doss","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New approaches to chronic hepatitis B","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.virol.2026.110977_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib21","first-page":"131","article-title":"Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro","volume":"20","author":"Favre","year":"2003","journal-title":"ALTEX"},{"key":"10.1016\/j.virol.2026.110977_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106143","article-title":"A hepatitis B virus-free cccDNA-Producing stable cell for antiviral screening","volume":"237","author":"Feng","year":"2025","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.virol.2026.110977_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12072-018-9884-8","article-title":"Global HBV burden: guesstimates and facts","volume":"12","author":"Ginzberg","year":"2018","journal-title":"Hepatol. Int."},{"issue":"6","key":"10.1016\/j.virol.2026.110977_bib24","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.msec.2009.02.016","article-title":"Patterning multiple cell types in Co-Cultures: a review","volume":"29","author":"Goubko","year":"2009","journal-title":"Mater. Sci. Eng. C"},{"issue":"7","key":"10.1016\/j.virol.2026.110977_bib26","doi-asserted-by":"crossref","DOI":"10.32604\/biocell.2024.051095","article-title":"Three-dimensional cell-based strategies for liver regeneration","volume":"48","author":"Guo","year":"2024","journal-title":"Biocell"},{"key":"10.1016\/j.virol.2026.110977_bib25","article-title":"In vitro cell culture models to study hepatitis B and D virus infection","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcmgh.2017.11.005","article-title":"Engineered livers for infectious diseases","volume":"5","author":"Gural","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2026.110977_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virol.2021.03.012","article-title":"A primary human hepatocyte\/hepatic stellate cell Co-Culture system for improved in Vitro HBV replication","volume":"559","author":"Han","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.110977_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.574047","article-title":"Liver organoids: recent developments, limitations and potential","volume":"8","author":"Harrison","year":"2021","journal-title":"Front. Med."},{"issue":"8","key":"10.1016\/j.virol.2026.110977_bib30","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4392","article-title":"Production of recombinant hepatitis B virus (HBV) and detection of HBV in infected human liver organoids","volume":"12","author":"Hossain","year":"2022","journal-title":"Bio-protocol"},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2018.06.093","article-title":"Cell and animal models for studying hepatitis B virus infection and drug development","volume":"156","author":"Hu","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2026.110977_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmt.2024.100067","article-title":"Developing biotechnologies in organoids for liver cancer","volume":"9","author":"Hu","year":"2025","journal-title":"Biomedical Technology"},{"issue":"7436","key":"10.1016\/j.virol.2026.110977_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In vitro expansion of single Lgr5+ liver stem cells induced by wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/sci7010027","article-title":"An overview on spheroid and organoid models in applied studies","volume":"7","author":"\u017divkovi\u0107","year":"2025","journal-title":"Sci"},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2026.110977_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110265","article-title":"Long-term 3D cell culture models for hepatitis B virus studies","volume":"600","author":"Jones","year":"2024","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/mi8010027","article-title":"Human liver sinusoid on a chip for hepatitis B virus replication study","volume":"8","author":"Kang","year":"2017","journal-title":"Micromachines"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2026.110977_bib39","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.51335\/organoid.2024.4.e11","article-title":"Three-dimensional liver organoids as a novel platform for studying hepatitis B virus infection","volume":"4","author":"Kim","year":"2024","journal-title":"Organoid"},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib40","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1083\/jcb.101.3.914","article-title":"Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities","volume":"101","author":"Landry","year":"1985","journal-title":"The Journal of cell biology"},{"issue":"10","key":"10.1016\/j.virol.2026.110977_bib42","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/biomimetics10100639","article-title":"Advanced 3D in vitro liver fibrosis models: spheroids, organoids, and liver-on-chips","volume":"10","author":"Lee","year":"2025","journal-title":"Biomimetics"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib41","doi-asserted-by":"crossref","DOI":"10.1063\/5.0030693","article-title":"Modeling the tumor immune microenvironment for drug discovery using 3D culture","volume":"5","author":"Lee","year":"2021","journal-title":"APL Bioeng."},{"key":"10.1016\/j.virol.2026.110977_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02667","article-title":"Mechanisms of immune tolerance in liver transplantation-crosstalk between alloreactive T cells and liver cells with therapeutic prospects","volume":"10","author":"Lei","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib46","article-title":"Innate immune recognition in hepatitis B virus infection","volume":"16","author":"Li","year":"2025","journal-title":"Virulence"},{"key":"10.1016\/j.virol.2026.110977_bib44","series-title":"Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs","first-page":"109","article-title":"Cell culture models and animal models for HBV study","author":"Li","year":"2020"},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113918","article-title":"Integration of kupffer cells into human iPSC-Derived liver organoids for modeling liver dysfunction in sepsis","volume":"43","author":"Li","year":"2024","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2013.07.001","article-title":"Genetic and epigenetic variations in iPSCs: potential causes and implications for application","volume":"13","author":"Liang","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.virol.2026.110977_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29232","article-title":"Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoids","volume":"95","author":"Lim","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2026.110977_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1169601","article-title":"The role of regulatory T cells and follicular T helper cells in HBV infection","volume":"14","author":"Lin","year":"2023","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.virol.2026.110977_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00849-22","article-title":"Establishment and characterization of an HBV viral spread and infectious system following long-term passage of an HBV clinical isolate in the primary human hepatocyte and fibroblast coculture system","volume":"96","author":"Liu","year":"2022","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41420-024-02016-0","article-title":"Sponging of five tumour suppressor miRNAs by lncRNA-KCNQ1OT1 activates BMPR1A\/BMPR1B-ACVR2A\/ACVR2B signalling and promotes chemoresistance in hepatocellular carcinoma","volume":"10","author":"Majumdar","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.virol.2026.110977_bib52","article-title":"Liver-on-Chips for drug discovery and development","volume":"27","author":"Mehta","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.virol.2026.110977_bib53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","article-title":"Recapitulation of hepatitis B virus\u2013host interactions in liver organoids from human induced pluripotent stem cells","volume":"35","author":"Nie","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib54","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-018-02969-8","article-title":"3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection","volume":"9","author":"Ortega-Prieto","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.virol.2026.110977_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150375","article-title":"Toolbox for creating three-dimensional liver models","volume":"731","author":"Panchuk","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cei\/uxae004","article-title":"Revolutionizing immune research with organoid-based Co-Culture and chip systems","volume":"218","author":"Papp","year":"2024","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148667","article-title":"Human liver infection in a dish: easy-to-build 3D liver models for studying microbial infection","volume":"11","author":"Petropolis","year":"2016","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.virol.2026.110977_bib59","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.3390\/cancers13143417","article-title":"Three-dimensional culture models to study innate anti-tumor immune response: advantages and disadvantages","volume":"13","author":"Poggi","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib60","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41598-025-31044-8","article-title":"3D Co-Cultures of primary human hepatocytes and kupffer-like cells to address innate immune responses to rAAV","volume":"16","author":"Ramella Gal","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2026.110977_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.02.024","article-title":"3D human liver organoids: an in Vitro platform to investigate HBV infection, replication and liver tumorigenesis","volume":"506","author":"Rao","year":"2021","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib62","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/liv.15805","article-title":"Targeted HBx gene editing by CRISPR\/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells","volume":"44","author":"Rawal","year":"2024","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.virol.2026.110977_bib63","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4358","article-title":"Maintenance and HBV infection of human liver organoids","volume":"12","author":"Romal","year":"2022","journal-title":"Bio-protocol"},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib64","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0022-3549(15)00192-6","article-title":"Co-Culture of hepatocytes and kupffer cells as an in vitro model of inflammation and drug-induced hepatotoxicity","volume":"105","author":"Rose","year":"2016","journal-title":"J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/toxsci\/kfac061","article-title":"Microphysiological systems evaluation: experience of TEX-VAL tissue chip testing consortium","volume":"188","author":"Rusyn","year":"2022","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.virol.2026.110977_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jmii.2014.08.008","article-title":"Hepatitis B virus infection and replication in a new cell culture system established by fusing HepG2 cells with primary human hepatocytes","volume":"49","author":"Sai","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.virol.2026.110977_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152651","article-title":"Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS)","volume":"448","author":"Sakolish","year":"2021","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/srep45698","article-title":"Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection","volume":"7","author":"Sakurai","year":"2017","journal-title":"Sci. Rep."},{"issue":"7244","key":"10.1016\/j.virol.2026.110977_bib69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.virol.2026.110977_bib70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/v9050125","article-title":"A role for the host DNA damage response in hepatitis B virus cccDNA Formation\u2014And beyond?","volume":"9","author":"Schreiner","year":"2017","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.virol.2026.110977_bib71","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"33","key":"10.1016\/j.virol.2026.110977_bib72","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1073\/pnas.1412631111","article-title":"Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems","volume":"111","author":"Shlomai","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.virol.2026.110977_bib73","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12072-023-10556-3","article-title":"Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes","volume":"17","author":"Song","year":"2023","journal-title":"Hepatol. Int."},{"issue":"11","key":"10.1016\/j.virol.2026.110977_bib74","article-title":"YAP mediates HIV-related liver fibrosis","volume":"6","author":"Spalding","year":"2024","journal-title":"JHEP Rep."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0092-8674(86)90364-8","article-title":"Production of Hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA","volume":"47","author":"Sureau","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.virol.2026.110977_bib75","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.002170","article-title":"Hepatitis B virus is a stealth virus that minimizes proteomic and secretomic changes in primary human hepatocytes","volume":"106","author":"\u0160taflov\u00e1","year":"2025","journal-title":"J. Gen. Virol."},{"issue":"7","key":"10.1016\/j.virol.2026.110977_bib77","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/vaccines12070710","article-title":"A comprehensive review of Hepatitis B vaccine nonresponse and associated risk factors","volume":"12","author":"Tahir","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01024-9","article-title":"Human organoids in basic research and clinical applications","volume":"7","author":"Tang","year":"2022","journal-title":"Sig Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib79","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.stem.2016.06.017","article-title":"Molecular obstacles to clinical translation of iPSCs","volume":"19","author":"Tapia","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.virol.2026.110977_bib80","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.24760","article-title":"Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing","volume":"55","author":"Tost\u00f5es","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.virol.2026.110977_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.101422","article-title":"Hepatitis B Virus-KMT2B integration drives hepatic oncogenic processes in a human gene-edited induced pluripotent stem cells-derived model","volume":"19","author":"Tsuchiya","year":"2025","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2026.110977_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.virol.2026.110977_bib83","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3390\/ijms18091952","article-title":"Induced pluripotent stem cells: advances in the quest for genetic stability during reprogramming process","volume":"18","author":"Turinetto","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.110977_bib84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2023.04.054","article-title":"HepaSH cells: experimental human hepatocytes with lesser inter-individual variation and more sustainable availability than primary human hepatocytes","volume":"663","author":"Uehara","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41591-020-01145-0","article-title":"Modeling human adaptive immune responses with tonsil organoids","volume":"27","author":"Wagar","year":"2021","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.virol.2026.110977_bib86","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.virs.2023.10.007","article-title":"Recent advances in understanding T cell activation and exhaustion during HBV infection","volume":"38","author":"Wang","year":"2023","journal-title":"Virol. Sin."},{"issue":"3","key":"10.1016\/j.virol.2026.110977_bib87","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcmgh.2017.11.007","article-title":"A cell culture platform to maintain long-term phenotype of primary human hepatocytes and endothelial cells","volume":"5","author":"Ware","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2026.110977_bib88","series-title":"Hepatitis B Vaccines: WHO Position Paper \u2013 July 2017; Weekly Epidemiological Record","first-page":"24","year":"2017"},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib89","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hep.30815","article-title":"Analysis of host responses to hepatitis B and Delta viral infections in a micro-scalable hepatic Co-Culture System","volume":"71","author":"Winer","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2026.110977_bib90","series-title":"Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries","year":"2024"},{"issue":"4","key":"10.1016\/j.virol.2026.110977_bib91","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bjid.2015.05.006","article-title":"Natural killer cells in hepatitis B virus infection","volume":"19","author":"Wu","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110977_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: formation, regulation and therapeutic potential","volume":"180","author":"Xia","year":"2020","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.virol.2026.110977_bib94","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jhep.2024.01.026","article-title":"HIV coinfection exacerbates HBV-Induced liver fibrogenesis through a HIF-1\u03b1- and TGF-\u03921-Dependent pathway","volume":"80","author":"Xu","year":"2024","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.virol.2026.110977_bib93","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12985-021-01580-6","article-title":"Advances in HBV infection and replication systems in vitro","volume":"18","author":"Xu","year":"2021","journal-title":"Virol. J."},{"issue":"9","key":"10.1016\/j.virol.2026.110977_bib95","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1073\/pnas.84.9.2678","article-title":"Hepatitis B Virus (HBV) particles are produced in a cell culture System by transient expression of transfected HBV DNA","volume":"84","author":"Yaginuma","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.virol.2026.110977_bib96","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human Hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.virol.2026.110977_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1488527","article-title":"Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies","volume":"14","author":"Yu","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"8","key":"10.1016\/j.virol.2026.110977_bib98","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000506","article-title":"Long-Term HBV infection of engineered cultures of induced pluripotent stem cell-derived hepatocytes","volume":"8","author":"Yuan","year":"2024","journal-title":"Hepatol. Commun."},{"issue":"9","key":"10.1016\/j.virol.2026.110977_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402946","article-title":"Immune-Infiltrated cancer spheroid model with vascular recirculation reveals temporally dependent and tissue-specific macrophage recruitment","volume":"14","author":"Zhang","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.virol.2026.110977_bib99","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.4c00147","article-title":"Progress of infection and replication systems of Hepatitis B virus","author":"Zhang","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:38:00Z","timestamp":1781051880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":101,"alternative-id":["S0042682226001923"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.110977","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-dimensional culture models of hepatitis B virus infection: Progress, challenges, and opportunities","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.110977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110977"}}